Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis

被引:1
|
作者
Patil, Rajashri [1 ]
Mukhida, Sahjid [1 ]
Ajagunde, Jyoti [1 ]
Khan, Uzair [1 ]
Khan, Sameena [1 ]
Gandham, Nageswari [1 ]
Vyawhare, Chanda [1 ]
Das, Nikunja K. [1 ]
Mirza, Shahzad [1 ]
机构
[1] Dr DY Patil Vidyapeeth, Dr DY Patil Med Coll Hosp & Res Ctr, Dept Microbiol, Pune 18, India
关键词
COVID-19-associated mucormycosis; machine learning; mucormycosis; rhino-orbito-cerebral mucormycosis;
D O I
10.2217/fmb-2023-0190
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Aim: The study aimed to identify quantitative parameters that increase the risk of rhino-orbito-cerebral mucormycosis, and subsequently developed a machine learning model that can anticipate susceptibility to developing this condition. Methods: Clinicopathological data from 124 patients were used to quantify their association with COVID-19-associated mucormycosis (CAM) and subsequently develop a machine learning model to predict its likelihood. Results: Diabetes mellitus, noninvasive ventilation and hypertension were found to have statistically significant associations with radiologically confirmed CAM cases. Conclusion: Machine learning models can be used to accurately predict the likelihood of development of CAM, and this methodology can be used in creating prediction algorithms of a wide variety of infections and complications. Fungal infections caused by the Mucorales order of fungi usually target patients with a weakened immune system. They are usually also associated with abnormal blood sugar states, such as in diabetic patients. Recent work during the COVID-19 outbreak suggested that excessive steroid use and diabetes may be behind the rise in fungal infections caused by Mucorales, known as mucormycosis, in India, but little work has been done to see whether we can predict the risk of mucormycosis. This study found that these fungal infections need not necessarily be caused by Mucorales species, but by a wide variety of fungi that target patients with weak immune systems. Secondly, we found that diabetes, breathing-assisting devices and high blood pressure states had associations with COVID-19-associated fungal infections. Finally, we were able to develop a machine learning model that showed high accuracy when predicting the risk of development of these fungal infections.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [21] Covid-19-associated mucormycosis in patients with renal failure
    Patil, Ankita
    Rao, Nikhil
    Kumar, Kruteesh
    Modi, Tulsi
    Gandhi, Chintan
    Deb, Satarupa
    Bose, Sreyashi
    Saxena, Nikhil
    Katyal, Abhinav
    Thakare, Sayali
    Pajai, Atim E.
    Bajpai, Divya
    Jamale, Tukaram E.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2022, 35 (03): : 187 - 189
  • [22] Commentary: Combating COVID-19-associated mucormycosis with limited resources
    Kim, Usha
    Kulkarni, Pooja
    Saini, Pragya
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (06) : 2169 - 2169
  • [23] COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
    Hussain, Salman
    Baxi, Harveen
    Riad, Abanoub
    Klugarova, Jitka
    Pokorna, Andrea
    Slezakova, Simona
    Licenik, Radim
    Najmi, Abul Kalam
    Klugar, Miloslav
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (19)
  • [24] Renal infarction due to COVID-19-associated renal mucormycosis
    Kurien, Anila Abraham
    Srinivasaprasad, Nagalakshmi Dhanapal
    Valavan, Kaliyaperumal Thirumal
    KIDNEY INTERNATIONAL, 2022, 101 (03) : 655 - 655
  • [25] COVID-19-associated mucormycosis: An updated systematic review of literature
    Pal, Rimesh
    Singh, Birgurman
    Bhadada, Sanjay Kumar
    Banerjee, Mainak
    Bhogal, Ranjitpal Singh
    Hage, Neemu
    Kumar, Ashok
    MYCOSES, 2021, 64 (12) : 1452 - 1459
  • [26] Distinguishing Characteristics of COVID-19-Associated Mucormycosis; a Case Series
    Samimiardestani, Seyedhadi
    Irani, Shirin
    Hasibi, Mehrdad
    Seyedahadi, Maral
    Bastaninejad, Shahin
    Firouzifar, Mohammadreza
    Ardehali, Mojataba Mohammadi
    Berijani, Sina
    Erfanian, Reza
    Kazemi, Mohammad Ali
    Etemadi-Aleagha, Afshar
    Rahimi, Abolfazl
    Yarandi, Kourosh Karimi
    Ahadi, Samira
    ARCHIVES OF ACADEMIC EMERGENCY MEDICINE, 2022, 10 (01)
  • [27] COVID-19-associated mucormycosis: Case report and systematic review
    Dilek, Ahmet
    Ozaras, Resat
    Ozkaya, Sevket
    Sunbul, Mustafa
    Sen, Elif Itir
    Leblebicioglu, Hakan
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 44
  • [28] COVID-19-associated disseminated mucormycosis: An autopsy case report
    Daisuke Kyuno
    Terufumi Kubo
    Mitsuhiro Tsujiwaki
    Shintaro Sugita
    Michiko Hosaka
    Hazuki Ito
    Keisuke Harada
    Akira Takasawa
    Yusaku Kubota
    Kumi Takasawa
    Yusuke Ono
    Kazufumi Magara
    Eichi Narimatsu
    Tadashi Hasegawa
    Makoto Osanai
    World Journal of Clinical Cases, 2022, 10 (28) : 10358 - 10365
  • [29] COVID-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg
    Parsaei, Amirhossein
    Kooshki, Ashkan Mohammadi
    Nasri, Hamid
    Hassanzadeh, Shakiba
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2022, 51 (02) : 473 - 475
  • [30] COVID-19-Associated Mucormycosis: A Battle Against Fatal Menace
    Sanchetee, Pratap
    Rajan, Rajeswari
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (03) : 336 - 337